Skip to content
Screener

Boston Scientific BSX Cardiovascular — Goodwill

Other segment segments

MedSurg
$7.98B+6.4%

Similar metrics at other companies

Constellation Brands logo
STZConstellationwinesandspirits — Goodwill
$5.23B+2.1%
Dycom Industries logo
DYCommunications — Goodwill
$332.65M—
Lennar logo
LENHomebuilding — Goodwill
$3.44B0.0%
Coherent logo
COHRIndustrial — Goodwill
$3.25B—
UnitedHealth Group logo
UNHUnitedHealthcare — Goodwill
$27.2B+0.1%
Lennar logo
LENMultifamily — Goodwill
$0—

Other financials

Income statement

See full
Revenue$5.4B+7.5%
Gross profit$3.8B+12.4%
Operating income$1.2B+43.8%
Net income$907.0M+14.1%
EPS (diluted)$0.61+15.1%

Balance sheet

See full
Cash & equivalents$850.0M+146%
Total debt$659.0M-94.1%
Total equity$25.9B+16.4%
Total assets$44.4B+10.5%

Cash flow

See full
Operating cash flow$348.0M-35.7%
CapEx$177.0M-5.3%
Free cash flow$171.0M-51.7%

Valuation

See full
Market cap$69.19B-54.6%
P/E18.9×-42.3×
P/S3.3×-5.0×

Profitability

See full
Gross margin69.9%+1.7pp
Operating margin19.8%+2.8pp
Net margin17.5%+4.0pp
FCF margin16.9%-0.3pp

Returns & leverage

See full
Return on equity14.8%+5.2pp
Debt / equity0×-0.5×
Current ratio1.9×+0.4×

Where this comes from

Reported directly by Boston Scientific in its filing.

Tagged under the XBRL concept us-gaap:Goodwill.

The source filing: Boston Scientific’s 10-Q, filed May 1, 2026.

Filed
May 1, 2026, 6:25 AM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0000885725-26-000033
(in millions)Med SurgCardiovascularTotal
Balance as of December 31, 2025$7,709$10,574$18,282
Goodwill acquired274—274
Impact of foreign currency fluctuations and purchase price adjustments(5)(14)(19)
Balance as of March 31, 2026$7,977$10,560$18,536

ITEM 1. CONSOLIDATED FINANCIAL STATEMENTS

FAQ

What is Boston Scientific's cardiovascular — goodwill?
Boston Scientific (BSX) reported cardiovascular — goodwill of $10.56B in Q1 2026.
How has Boston Scientific's cardiovascular — goodwill changed year-over-year?
Boston Scientific's cardiovascular — goodwill increased by 7.3% year-over-year, from $9.84B to $10.56B.
What is the long-term trend for Boston Scientific's cardiovascular — goodwill?
Over 4 years (2021 to 2025), Boston Scientific's cardiovascular — goodwill has grown at a 13.7% compound annual growth rate (CAGR), from $24.82B to $41.49B.
What does cardiovascular — goodwill mean?
Represents the total carrying value of goodwill specifically attributed to the Cardiovascular business segment. This asset arises from business combinations where the purchase price exceeded the fair value of identifiable net assets, reflecting the segment's brand reputation and market position.

Ask your AI about Boston Scientific's cardiovascular — goodwill.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude